In conclusion, numerical measures of circulating Tfr, Tfh and B10 cells appear to correlate with disease activity of AChR+ MG; however, none of these populations shows sufficient sensitivity or specificity to serve as a biomarker for the disease. This evidence concerns the gene TFRC and myasthenia gravis.